Author

Annalyssa N. Long

Fred Hutch Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alexandre V. Vinaud HirayamaiD· 1 shared Anna ElziD· 1 shared Bobbie‐Jo Webb‐RobertsoniD· 1 shared David Richard GlassiD· 1 shared Derrik GratziD· 1 shared Emily C. LiangiD· 1 shared Evan William NewelliD· 1 shared Heather Herd GustafsoniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexandre V. Vinaud HirayamaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Coordinated expansion of CD163⁺ monocytes and immature CD177⁺ neutrophils marks severe neurotoxicity after CD19 CAR T cell therapy

Tony Chour, Nikhita H. Poole, Hugh R. MacMillan, Katelyn Burleigh, David Richard Glass, Emily C. Liang, Ryan Basom, Bobbie‐Jo Webb‐Robertson, Kelly Stratton, Derrik Gratz, Annalyssa N. Long, Anna Elz, Jennifer Jing Huang, Alexandre V. Vinaud Hirayama, Stanley R. Riddell, , Sylvain Simon

The paper identifies CD163+ monocytes and immature CD177+ neutrophils as markers of severe neurotoxicity after CD19 CAR T cell therapy through multi-omics profiling.

bioRxiv · Jul 9, 2026 · PreprintImmunology